Sectors
MPLT
MapLight Therapeutics, Inc.
12.97
2 x 8.85
1 x 12.84
bid
ask
+
0.37
2.94%
2 @ 07:30 PM
12.97 +0.00 (0.00%)
| Ytd | -26.18% | |
| 1y | -29.28% |
12.12
day range
13.07
9.10
52 week range
40.43
| Open | 12.59 | Prev Close | 12.60 | Low | 12.12 | High | 13.07 | Mkt Cap | 601.52M |
| Vol | 440.58K | Avg Vol | 835.35K | EPS | -20.55 | P/E | N/A | Forward P/E | -10.51 |
| Beta | N/A | Short Ratio | 5.58 | Inst. Own | 56.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 23.80 | 200-d Avg | 21.99 | 1yr Est | 41.50 |
| Income Statement | |||
| Operating Expenses | 63.55M | ||
| Research and Development Expense | 53.44M | ||
| Selling, General and Administrative Expense | 10.11M | ||
| Operating Income | -63.55M | ||
| Net Income | -60.19M | ||
| Net Income Common Stock | -60.19M | ||
| Net Income Common Stock (USD) | -60.19M | ||
| Consolidated Income | -60.19M | ||
| Earnings per Basic Share | -1.32 | ||
| Earnings per Basic Share (USD) | -1.32 | ||
| Earnings per Diluted Share | -1.32 | ||
| Earning Before Interest & Taxes (EBIT) | -60.19M | ||
| Earning Before Interest & Taxes (USD) | -60.19M | ||
| Weighted Average Shares | 45.43M | ||
| Weighted Average Shares Diluted | 45.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 71.84M | ||
| Cash and Equivalents (USD) | 71.84M | ||
| Investments | 279.71M | ||
| Investments Current | 233.09M | ||
| Investments Non-Current | 46.62M | ||
| Current Assets | 318.79M | ||
| Property, Plant & Equipment Net | 2.50M | ||
| Total Assets | 368.35M | ||
| Debt Current | 1.23M | ||
| Total Debt | 1.99M | ||
| Current Liabilities | 19.29M | ||
| Debt Non-Current | 755.00K | ||
| Total Liabilities | 20.05M | ||
| Accumulated Retained Earnings (Deficit) | -481.38M | ||
| Accumulated Other Comprehensive Income | -944.00K | ||
| Shareholders Equity | 348.30M | ||
| Shareholders Equity (USD) | 348.30M | ||
| Assets Non-Current | 49.56M | ||
| Total Debt (USD) | 1.99M | ||
| Liabilities Non-Current | 755.00K | ||
| Trade and Non-Trade Payables | 2.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 364.00K | ||
| Net Cash Flow from Financing | 92.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 15.93M | ||
| Capital Expenditure | -22.00K | ||
| Issuance (Purchase) of Equity Shares | 92.00K | ||
| Net Cash Flow from Investing | 60.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 60.73M | ||
| Net Cash Flow from Operations | -44.87M | ||
| Share Based Compensation | 8.63M | ||